Influenza News

There are several methods and tools clinicians can utilize to improve vaccine confidence and boost immunization rates as the respiratory virus season approaches, according to an expert panel.

HHS announced that it will give Moderna around $176 million to accelerate the development of a messenger RNA-based pandemic influenza vaccine amid an ongoing outbreak of avian influenza.

We checked in with CDC Director Mandy K. Cohen, MD, MPH, for an update on the agency’s efforts to modernize the nation’s disease surveillance and data systems and improve how the CDC communicates with the public and physicians.

Participation in the Pediatric Academic Societies Meeting is back to pre-COVID-19 levels of engagement, according to one of the event’s program chairs.

Over the years, an old friend, Michael Cater, MD, a pediatrician at Children's Hospital of Orange County, California, has shared numerous interesting cases, some from exotic places during his time in the Army.

Moderna announced positive interim results from a phase 3 trial of its next-generation COVID-19 vaccine, which the company said will help pave the way for its combination shot against COVID-19 and influenza.

Personalized care could help patients and providers plan safe returns to work or school from respiratory illnesses, according to a research review.

The latest COVID-19 vaccines reduce the risk for hospitalization or visits to an ED or urgent care by around 50%, according to interim data published in MMWR.

Influenza vaccine manufacturers in the United States said this week that they have plans to remove a potentially extinct influenza B lineage from their vaccines and offer only trivalent shots next season.